How Michael Burry's Picks are Playing Out In 2025 ?
Introduction
In his Q4 2024 13F filing, Michael Burry’s Scion Asset Management disclosed 13 positions valued at $77.4 million. From the reported prices to today’s levels, the portfolio has produced a wide range of outcomes: Alibaba soared +40.31%, Molina Healthcare rose +14.07%, while VF Corp. and Bruker plunged –48.23% and –35.36%, respectively. Below we update each holding’s reported vs. current price performance and examine Burry’s possible rationale against early 2025 market themes.
Q4 2024 Portfolio at a Glance
| Company (Ticker) | Reported Price | Current Price | % Difference |
|---|---|---|---|
| Alibaba (BABA) | $84.79 | $118.97 | +40.31% |
| American Coastal (ACIC) | $13.46 | $11.16 | -17.09% |
| Baidu (BIDU) | $84.31 | $87.51 | +3.80% |
| Bruker (BRKR) | $58.62 | $37.89 | -35.36% |
| Canada Goose (GOOS) | $10.03 | $8.48 | -15.45% |
| Estée Lauder (EL) | $74.98 | $57.26 | -23.63% |
| HCA Healthcare (HCA) | $300.15 | $335.98 | +11.94% |
| JD.com (JD) | $34.67 | $33.56 | -3.20% |
| Magnera (MAGN) | $18.17 | $13.53 | -25.54% |
| Molina Healthcare (MOH) | $291.05 | $332.00 | +14.07% |
| Oscar Health (OSCR) | $13.44 | $12.01 | -10.64% |
| Pinduoduo (PDD) | $96.99 | $100.43 | +3.55% |
| VF Corp. (VFC) | $21.46 | $11.11 | -48.23% |
China Tech Reassessment
Alibaba, JD.com, Baidu & Pinduoduo
Burry’s largest convictions remain in Chinese tech, though performance varies. Alibaba delivered a commanding +40.31% gain on renewed growth and strategic spin-offs. Baidu’s +3.80% uptick reflects steady AI momentum, while Pinduoduo climbed +3.55% on expanding user engagement. JD.com, down –3.20%, underscores lingering margin pressure despite operational efficiencies. These results validate Burry’s value-oriented tilt toward China’s reopening.
Healthcare & Insurance
Molina, HCA, Oscar Health & American Coastal
Defensive healthcare and niche insurance names showed resilience. Molina Healthcare rose +14.07% on stable, government-backed revenues, and HCA Healthcare gained +11.94% via reliable hospital cash flows. Oscar Health’s –10.64% pullback follows heightened profit-taking in tech-driven insurers, while American Coastal’s –17.09% reflects reinsurance cost headwinds after recent storm activity.
Consumer Brands
Estée Lauder, VF Corp. & Canada Goose
Burry’s contrarian consumer bets faced steep drawdowns: Estée Lauder –23.63% on softer travel retail, VF Corp. –48.23% amid apparel weakness, and Canada Goose –15.45% with excess inventory. He appears to be targeting a long-term rebound in brand-owned franchises once discretionary spending recovers.
Industry & Science
Bruker & Magnera
Bruker’s –35.36% slide contrasts with expected R&D spending growth, while Magnera’s –25.54% decline highlights the risks inherent in recent spinoffs. Both names remain on Burry’s watchlist for potential special-situation upside if industrial demand rebounds.
The Big Picture
- Value vs. Growth: Heavy winners in Alibaba and Molina offset deep losses in VF and Bruker, underscoring his asymmetric value bias.
- Rate Environment: Preference for cash-flow generators and select tech amid rising interest rates.
- China Focus: Captured reopening tailwinds with varying success across e-commerce and AI plays.
- Defensive Balance: Healthcare & insurance allocations aim to cushion against broader market swings.
Conclusion
From the reported filing prices to today’s marks, Michael Burry’s Q4 2024 portfolio exhibits both standout gains—led by Alibaba (+40.31%) and Molina (+14.07%)—and notable drawdowns in consumer and industrial names. His thematic diversification across Chinese tech, defensive healthcare, contrarian consumer brands, and special-situation industrials continues to reflect a multi-scenario, deep-value framework tailored to early 2025’s macro landscape.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Please do your own research or consult a licensed advisor before making any investment decisions.
